{"id":131430,"date":"2023-02-22T11:57:03","date_gmt":"2023-02-22T11:57:03","guid":{"rendered":"https:\/\/fin2me.com\/?p=131430"},"modified":"2023-02-22T11:57:03","modified_gmt":"2023-02-22T11:57:03","slug":"these-23-biotech-stocks-generated-triple-digit-returns-in-just-6-months","status":"publish","type":"post","link":"https:\/\/fin2me.com\/business\/these-23-biotech-stocks-generated-triple-digit-returns-in-just-6-months\/","title":{"rendered":"These 23 Biotech Stocks Generated Triple-Digit Returns In Just 6 Months"},"content":{"rendered":"

The following stocks that were featured on our site between July and December 2022 delivered triple-digit gains. Were these stocks part of your portfolio? <\/p>\n\n\n\n
\n

Headlines<\/p>\n

Published Date<\/p>\n

Published Price<\/p>\n

Maximum Price Since Publishing<\/p>\n

Last Closing Price<\/p>\n

Max Gain %<\/p>\n

VIGL – Vigil Neuroscience’s IPO Lock-up Period Ends Tomorrow <\/p>\n

Jul.5<\/p>\n

$2.36<\/p>\n

$16.77<\/p>\n

$11.28<\/p>\n

610%<\/p>\n

CINC- CinCor Pharma’s IPO Lock-up Period Ends On July 6<\/p>\n

Jul.5<\/p>\n

$19.7<\/p>\n

$43.15<\/p>\n

$29.15<\/p>\n

119%<\/p>\n

GLSI – Greenwich LifeSciences Rallies On Removal Of Clinical Hold<\/p>\n

Jul.12<\/p>\n

$9.84<\/p>\n

$21.50<\/p>\n

$15.10<\/p>\n

118%<\/p>\n

FREQ – Will Frequency Hit The Right Notes? <\/p>\n

Jul.15<\/p>\n

$2.55<\/p>\n

$5.59<\/p>\n

$0.68<\/p>\n

119%<\/p>\n

VRNA – Will Verona’s COPD Trial Data ENHANCE Its Stock Price?<\/p>\n

Jul.19<\/p>\n

$5.98<\/p>\n

$26.44<\/p>\n

$20.54<\/p>\n

342%<\/p>\n

VKTX – Viking Therapeutics To Resume Phase Ib Trial Of VK0214 <\/p>\n

Jul.19<\/p>\n

$3.45<\/p>\n

$11.80<\/p>\n

$11.03<\/p>\n

242%<\/p>\n

NUVL – Will Nuvalent’s ARROS-1 Hit The Target?<\/p>\n

Aug.10<\/p>\n

$17.00<\/p>\n

$40.43<\/p>\n

$31.36<\/p>\n

137%<\/p>\n

VTYX – Ventyx Biosciences Awaits VTX958 Trial Data <\/p>\n

Aug.11<\/p>\n

$17.19<\/p>\n

$44.98<\/p>\n

$42.50<\/p>\n

161%<\/p>\n

WVE – What’s Causing Wave To Rise?<\/p>\n

Aug.12<\/p>\n

$3.14<\/p>\n

$7.12<\/p>\n

$4.32<\/p>\n

127%<\/p>\n

AKRO – Akero – Of NASH And HARMONY…<\/p>\n

Aug.22<\/p>\n

$11.86<\/p>\n

$54.88<\/p>\n

$44.10<\/p>\n

362%<\/p>\n

SPRB – Spruce Biosciences – Eyeing PCOS, CAH Treatment Markets<\/p>\n

Sep.15<\/p>\n

$1.74<\/p>\n

$3.57<\/p>\n

$2.40<\/p>\n

105%<\/p>\n

AKUS – Did You Hear This? <\/p>\n

Sep.15<\/p>\n

$4.50<\/p>\n

$15.50<\/p>\n

NA<\/p>\n

244%<\/p>\n

ANTX – AN2 Therapeutics’ IPO Lock-up Period Ends On Sep. 21<\/p>\n

Sep.20<\/p>\n

$9.58<\/p>\n

$21.04<\/p>\n

$13.32<\/p>\n

119%<\/p>\n

MHUA – Meihua International – Getting Back On Track?<\/p>\n

Sep.20<\/p>\n

$5.52<\/p>\n

$39.00<\/p>\n

$39.00<\/p>\n

606%<\/p>\n

HROW – Will Harrow’s AMP-100 Score FDA Nod?<\/p>\n

Sep.21<\/p>\n

$8.35<\/p>\n

$20.31<\/p>\n

$16.96<\/p>\n

143%<\/p>\n

MDGL – Madrigal – Gearing Up For MAESTRO-NASH Data<\/p>\n

Sep.26<\/p>\n

$64.99<\/p>\n

$315.45<\/p>\n

$288.76<\/p>\n

385%<\/p>\n

IMVT – Immunovant’s Batoclimab – A Pipeline In Itself? <\/p>\n

Oct.5<\/p>\n

$7.84<\/p>\n

$20.24<\/p>\n

$18.16<\/p>\n

158%<\/p>\n

ALBO – Can Albireo’s Bylvay ASSERT Efficacy In Alagille Syndrome?<\/p>\n

Oct.6<\/p>\n

$20.00<\/p>\n

$45.23<\/p>\n

$43.76<\/p>\n

126%<\/p>\n

ARDX – Will Ardelyx’ Xphozah Make It To The Finish Line?<\/p>\n

Oct.13<\/p>\n

$1.34<\/p>\n

$3.43<\/p>\n

$2.94<\/p>\n

155%<\/p>\n

MLTX – MoonLake – Developing Next-level Therapies To Elevate Care<\/p>\n

Oct.19<\/p>\n

$8.28<\/p>\n

$18.71<\/p>\n

$18.18<\/p>\n

125%<\/p>\n

BIVI – Will Christmas Come Early For BioVie?<\/p>\n

Nov.9<\/p>\n

$4.56<\/p>\n

$14.38<\/p>\n

$5.64<\/p>\n

215%<\/p>\n

NAMS – NewAmsterdam Pharma Exploring High Risk Cardiovascular Disease Landscape<\/p>\n

Nov.30<\/p>\n

$9.00<\/p>\n

$18.70<\/p>\n

$13.45<\/p>\n

107%<\/p>\n

RIGL – Rigel Soars As FDA Approves Acute Myeloid Leukemia Drug<\/p>\n

Dec.2<\/p>\n

$0.94<\/p>\n

$2.04<\/p>\n

$1.59<\/p>\n

117%<\/p>\n

*The “Last Closing Price” refers to the closing price recorded on February 21, 2023. <\/p>\n

Source: Read Full Article<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

The following stocks that were featured on our site between July and December 2022 delivered triple-digit gains. Were these stocks part of your portfolio? Headlines […]<\/p>\n","protected":false},"author":3,"featured_media":131429,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[],"yoast_head":"\nThese 23 Biotech Stocks Generated Triple-Digit Returns In Just 6 Months - Fin2me<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/fin2me.com\/business\/these-23-biotech-stocks-generated-triple-digit-returns-in-just-6-months\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"These 23 Biotech Stocks Generated Triple-Digit Returns In Just 6 Months - Fin2me\" \/>\n<meta property=\"og:description\" content=\"The following stocks that were featured on our site between July and December 2022 delivered triple-digit gains. Were these stocks part of your portfolio? Headlines [...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/fin2me.com\/business\/these-23-biotech-stocks-generated-triple-digit-returns-in-just-6-months\/\" \/>\n<meta property=\"og:site_name\" content=\"Fin2me\" \/>\n<meta property=\"article:published_time\" content=\"2023-02-22T11:57:03+00:00\" \/>\n<meta name=\"author\" content=\"Mark\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/fin2me.com\/wp-content\/uploads\/2023\/02\/These-23-Biotech-Stocks-Generated-Triple-Digit-Returns-In-Just-6-Months-.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Mark\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/fin2me.com\/business\/these-23-biotech-stocks-generated-triple-digit-returns-in-just-6-months\/\",\"url\":\"https:\/\/fin2me.com\/business\/these-23-biotech-stocks-generated-triple-digit-returns-in-just-6-months\/\",\"name\":\"These 23 Biotech Stocks Generated Triple-Digit Returns In Just 6 Months - Fin2me\",\"isPartOf\":{\"@id\":\"https:\/\/fin2me.com\/#website\"},\"datePublished\":\"2023-02-22T11:57:03+00:00\",\"dateModified\":\"2023-02-22T11:57:03+00:00\",\"author\":{\"@id\":\"https:\/\/fin2me.com\/#\/schema\/person\/ad0e9920e03d3b41c7ad02a18375d76a\"},\"breadcrumb\":{\"@id\":\"https:\/\/fin2me.com\/business\/these-23-biotech-stocks-generated-triple-digit-returns-in-just-6-months\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/fin2me.com\/business\/these-23-biotech-stocks-generated-triple-digit-returns-in-just-6-months\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/fin2me.com\/business\/these-23-biotech-stocks-generated-triple-digit-returns-in-just-6-months\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/fin2me.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Business\",\"item\":\"https:\/\/fin2me.com\/category\/business\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"These 23 Biotech Stocks Generated Triple-Digit Returns In Just 6 Months\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/fin2me.com\/#website\",\"url\":\"https:\/\/fin2me.com\/\",\"name\":\"Fin2me\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/fin2me.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/fin2me.com\/#\/schema\/person\/ad0e9920e03d3b41c7ad02a18375d76a\",\"name\":\"Mark\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/fin2me.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/39b72719fb75a2d3c7d7695026648602?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/39b72719fb75a2d3c7d7695026648602?s=96&d=mm&r=g\",\"caption\":\"Mark\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"These 23 Biotech Stocks Generated Triple-Digit Returns In Just 6 Months - Fin2me","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/fin2me.com\/business\/these-23-biotech-stocks-generated-triple-digit-returns-in-just-6-months\/","og_locale":"en_US","og_type":"article","og_title":"These 23 Biotech Stocks Generated Triple-Digit Returns In Just 6 Months - Fin2me","og_description":"The following stocks that were featured on our site between July and December 2022 delivered triple-digit gains. Were these stocks part of your portfolio? Headlines [...]","og_url":"https:\/\/fin2me.com\/business\/these-23-biotech-stocks-generated-triple-digit-returns-in-just-6-months\/","og_site_name":"Fin2me","article_published_time":"2023-02-22T11:57:03+00:00","author":"Mark","twitter_card":"summary_large_image","twitter_image":"https:\/\/fin2me.com\/wp-content\/uploads\/2023\/02\/These-23-Biotech-Stocks-Generated-Triple-Digit-Returns-In-Just-6-Months-.jpg","twitter_misc":{"Written by":"Mark","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/fin2me.com\/business\/these-23-biotech-stocks-generated-triple-digit-returns-in-just-6-months\/","url":"https:\/\/fin2me.com\/business\/these-23-biotech-stocks-generated-triple-digit-returns-in-just-6-months\/","name":"These 23 Biotech Stocks Generated Triple-Digit Returns In Just 6 Months - Fin2me","isPartOf":{"@id":"https:\/\/fin2me.com\/#website"},"datePublished":"2023-02-22T11:57:03+00:00","dateModified":"2023-02-22T11:57:03+00:00","author":{"@id":"https:\/\/fin2me.com\/#\/schema\/person\/ad0e9920e03d3b41c7ad02a18375d76a"},"breadcrumb":{"@id":"https:\/\/fin2me.com\/business\/these-23-biotech-stocks-generated-triple-digit-returns-in-just-6-months\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/fin2me.com\/business\/these-23-biotech-stocks-generated-triple-digit-returns-in-just-6-months\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/fin2me.com\/business\/these-23-biotech-stocks-generated-triple-digit-returns-in-just-6-months\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/fin2me.com\/"},{"@type":"ListItem","position":2,"name":"Business","item":"https:\/\/fin2me.com\/category\/business\/"},{"@type":"ListItem","position":3,"name":"These 23 Biotech Stocks Generated Triple-Digit Returns In Just 6 Months"}]},{"@type":"WebSite","@id":"https:\/\/fin2me.com\/#website","url":"https:\/\/fin2me.com\/","name":"Fin2me","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/fin2me.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/fin2me.com\/#\/schema\/person\/ad0e9920e03d3b41c7ad02a18375d76a","name":"Mark","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/fin2me.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/39b72719fb75a2d3c7d7695026648602?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/39b72719fb75a2d3c7d7695026648602?s=96&d=mm&r=g","caption":"Mark"}}]}},"_links":{"self":[{"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/posts\/131430"}],"collection":[{"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/comments?post=131430"}],"version-history":[{"count":0,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/posts\/131430\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/media\/131429"}],"wp:attachment":[{"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/media?parent=131430"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/categories?post=131430"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/tags?post=131430"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}